Department of Obstetrics and Gynecology, University Hospital of Poitiers, Poitiers, France.
Department of Obstetrics and Gynecology, Regional Hospital of Angoulême, Angoulême, France.
Acta Obstet Gynecol Scand. 2020 Feb;99(2):259-266. doi: 10.1111/aogs.13712. Epub 2019 Sep 6.
The aim of this study was to compare the efficacy and maternal-neonatal morbidity between balloon catheter and oxytocin for induction of labor in women with a previous cesarean section and an unfavorable cervix.
This open-label randomized controlled trial took place in seven French hospitals. Inclusion criteria were medical indication for labor induction in pregnant women, ≥37 weeks, with lower segment cesarean section, Bishop score ≤4, no pre-labor rupture of membranes, singleton fetus in cephalic presentation. Women were allocated randomly to induction with a 50-mL balloon catheter for 12 hours or a low-dose oxytocin infusion. Primary outcome was the rate of vaginal birth. Secondary outcomes were maternal and neonatal complications.
The study enrolled 204 women from 26 December 2010 to 31 December 2013: 101 were allocated to receive balloon catheter and 103 to oxytocin. Vaginal birth rate was 50% (n = 51) in the balloon catheter group vs 37% (n = 38) in the oxytocin group (P = 0.050). Maternal and neonatal morbidity did not differ between balloon catheter and oxytocin groups: two uterine dehiscences vs one, one vs four maternal infections, five vs two hemorrhages and 11 vs five neonatal transfers, respectively. Heterogeneity of treatment effect for vaginal delivery was observed across initial Bishop scores. Balloon catheter was more effective for low values of bishop score.
Balloon catheter tended to be associated with a higher probability of vaginal delivery as compared with low-dose intravenous oxytocin when used for induction of labor in women with a previous cesarean section and low Bishop score at induction.
本研究旨在比较球囊导管与缩宫素用于有剖宫产史和宫颈条件不佳的产妇引产的疗效和母婴发病率。
这是一项在法国 7 家医院进行的开放性标签随机对照试验。纳入标准为有剖宫产史、孕龄≥37 周、下段剖宫产、Bishop 评分≤4、无产前胎膜早破、头位单胎的孕妇,因医学指征需要引产。将这些孕妇随机分为 12 小时球囊导管组或小剂量缩宫素组。主要结局是阴道分娩率。次要结局是母婴并发症。
该研究于 2010 年 12 月 26 日至 2013 年 12 月 31 日共纳入 204 名孕妇:101 名分配至球囊导管组,103 名分配至缩宫素组。球囊导管组阴道分娩率为 50%(n=51),缩宫素组为 37%(n=38)(P=0.050)。球囊导管组和缩宫素组的母婴发病率无差异:两组各有 1 例子宫破裂,1 例感染,5 例出血,11 例新生儿转科;而缩宫素组有 4 例感染,2 例出血,5 例新生儿转科。初始 Bishop 评分的不同,治疗效果也存在差异。球囊导管在 Bishop 评分较低时效果更好。
与小剂量静脉滴注缩宫素相比,球囊导管用于有剖宫产史和低 Bishop 评分的产妇引产时,更可能增加阴道分娩的机会。